Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
CMTA Appoints David Apple to Board of Directors
…to better understand potential treatments and cures for CMT. The CMTA is the leading patient advocacy organization driving CMT research. Its mission is to develop treatments and a cure for…
2020_CMTA_PFC_Demyelinating_Update_transcript
Columbus Walk4CMT
08/30/2025 @ 12:00 pm – 3:00 pm – Whether you walk, run or roll, we invite you to join us at the 2025 Columbus Walk 4 CMT for a nice and enjoyable day. Come out and connect with other people with Charcot-Marie-Tooth (CMT), families, and local companies while fundraising for a cure. Fun for all the whole family! About Walk 4 CMT Walk […]
New, Potentially Treatable, Type of CMT Discovered
New Type of CMT May Be Treatable Dr. Stephan Züchner A team led by Dr. Stephan Züchner at the University of Miami has discovered a new type of Charcot-Marie-Tooth (CMT)…
Central New Jersey Walk4CMT
09/20/2025 @ 9:00 am – 11:00 am – Whether you walk, run or roll, we invite you to join us at the 2025 Central New Jersey Walk4CMT for a nice and enjoyable day. Come out and connect with other people with Charcot-Marie-Tooth (CMT), families, and local companies while fundraising for a cure. Fun for all the whole family! About Walk 4 CMT Walk […]
CMT2F Natural History Study Nears Full Recruitment as Biomarker Analysis Begins
…their one-year follow-up visits—3 each from Iowa, London, and Rochester. Each participant has undergone Clinical Outcome Measure assessments, including the CMT Exam Score (CMTES), CMT Functional Outcomes Measure (CMT-FOM), and…
Bruce R Conklin, MD Joins the CMTA STAR Advisory Board
…utilization of these rapidly advancing technologies.” Dr. Conklin’s lab has been funded by the CMTA for research on CRISPR therapies for CMT2A, CMT2E, CMT2F. The promising findings from this initial…
DNA-Based Therapeutics: A Promising Future for CMT2E Treatment
…have made significant progress in DNA-based therapeutics. Their groundbreaking work targets the fundamental genetic cause of CMT2E. CMT2E is an axonal CMT (CMT2). Several different autosomal dominant mutations of the…
Boston Walk and Cycle 4CMT
09/29/2024 @ 9:00 am – 12:00 pm – Whether you walk, run or roll, we invite you to join us at the 2024 Boston Walk and Cycle 4 CMT on September 29th at 9:00am for a nice and enjoyable day. Come out and connect with other people with Charcot-Marie-Tooth (CMT), families, and local companies while fundraising for a cure. Fun for all the […]
CMTA Announces Its First Center of Excellence in Scotland
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) research, is proud to announce the designation of Katie Brennan, MD, PhD, at Queen Elizabeth University Hospital…